Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study.

@article{Yoshida2001AppraisalOT,
  title={Appraisal of transarterial immunoembolization for hepatocellular carcinoma: a clinicopathologic study.},
  author={Takeshi Yoshida and Masato Sakon and Koji Umeshita and Toshiharu Kanai and Akira Miyamoto and Tsutomu Takeda and Masahiro Gotoh and Hiroyuki Nakamura and Kenichi Wakasa and Morito Monden},
  journal={Journal of clinical gastroenterology},
  year={2001},
  volume={32 1},
  pages={59-65}
}
Recurrence of hepatocellular carcinoma (HCC) is frequent, even after apparently curative resection. Preoperative transcatheter arterial chemoembolization (TAE) does not improve disease-free survival after hepatic resection. We previously reported the potential usefulness of transarterial immunoembolization (TIE), a newly developed arterial embolization technique using OK-432 and fibrinogen, as preoperative treatment. In this study, we further investigated the effect of TIE by histologic… CONTINUE READING